Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sina Pharmed Salamat is an Iranian pharmaceutical company specializing in the development and production of high-tech peptide-based medicines and biosimilars. The company focuses on therapeutic areas such as endocrinology, reproductive health, and oncology, offering a portfolio that includes treatments for osteoporosis and hormonal disorders. Sina Pharmed utilizes advanced biotechnology and solid-phase peptide synthesis to manufacture complex molecules, including recombinant proteins and synthetic peptides. Their products, such as SinaParatide and SinaFact, serve as critical therapeutic options in the domestic and regional markets. The company maintains GMP-certified manufacturing facilities and is recognized for its capabilities in producing high-purity active pharmaceutical ingredients (APIs) for peptide drugs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sina pharmed salamat.